70 related articles for article (PubMed ID: 1414321)
1. [Local immunity following treatment with S-carboxymethylcysteine-lysine in tracheotomy patients].
Carlevato MT; Battaglio S; Galeazzi E; Bussi M
Acta Otorhinolaryngol Ital; 1992; 12(2):127-34. PubMed ID: 1414321
[TBL] [Abstract][Full Text] [Related]
2. [Mucoregulatory therapy in secreting disease of the middle ear].
Bonci M; Bozzi A
Minerva Med; 1994 Mar; 85(3):83-7. PubMed ID: 8196848
[TBL] [Abstract][Full Text] [Related]
3. [Examination about IgA, IgG, albumin and lysozyme content in nasal and tracheobronchial secretions in laryngectomized patients (author's transl)].
Baumann H; Meyer P; Zippel R
Laryngol Rhinol Otol (Stuttg); 1980 Nov; 59(11):724-6. PubMed ID: 7464357
[TBL] [Abstract][Full Text] [Related]
4. [Determination of 11S IgA in nasal secretions in the monitoring of local immunomodulating therapy].
Bussi M; Carlevato MT; Battaglio S; Galeazzi E; Omedé P; Cortesina G
Acta Otorhinolaryngol Ital; 1991; 11(1):35-43. PubMed ID: 1897369
[TBL] [Abstract][Full Text] [Related]
5. Effect of S-carboxymethylcysteine lysine salt on mucociliary clearance in rabbits with secretory cell metaplasia.
Daffonchio L; De Santi MM; Gardi C; Lungarella G; Omini C
Res Commun Mol Pathol Pharmacol; 1994 Oct; 86(1):59-74. PubMed ID: 7850257
[TBL] [Abstract][Full Text] [Related]
6. [Changes in IgA levels in nasal mucus after upper respiratory tract diseases in infants treated with carbocysteine].
Henocq A; Moreau C; Mallet E; Sauger F; de Menibus CH
Ann Otolaryngol Chir Cervicofac; 1985; 102(5):373-5. PubMed ID: 4037622
[TBL] [Abstract][Full Text] [Related]
7. The management of cystic fibrosis with carbocysteine lysine salt: single-blind comparative study with ambroxol hydrochloride.
Caramia G; Gagliardini R; Ruffini E; Osimani P; Nobilini A
J Int Med Res; 1995; 23(4):284-93. PubMed ID: 7589772
[TBL] [Abstract][Full Text] [Related]
8. The concentrations of IgA and free secretory piece in the nasal secretions of patients with recurrent respiratory infections.
Stanley PJ; Cole PJ
Clin Exp Immunol; 1985 Jan; 59(1):197-202. PubMed ID: 3918818
[TBL] [Abstract][Full Text] [Related]
9. Prevention of acute exacerbations of chronic obstructive bronchitis with carbocysteine lysine salt monohydrate: a multicenter, double-blind, placebo-controlled trial.
Allegra L; Cordaro CI; Grassi C
Respiration; 1996; 63(3):174-80. PubMed ID: 8739489
[TBL] [Abstract][Full Text] [Related]
10. Specific IgA and IgG antibodies to house dust mite Dermatophagoides farinae in nasal secretions.
Xiao SF; Okuda M; Ohnishi M; Okubo K
Arerugi; 1994 May; 43(5):634-44. PubMed ID: 8031257
[TBL] [Abstract][Full Text] [Related]
11. Pathophysiology of rhinitis. 1. Assessment of the sources of protein in methacholine-induced nasal secretions.
Raphael GD; Druce HM; Baraniuk JN; Kaliner MA
Am Rev Respir Dis; 1988 Aug; 138(2):413-20. PubMed ID: 3057965
[TBL] [Abstract][Full Text] [Related]
12. The role for S-carboxymethylcysteine (carbocisteine) in the management of chronic obstructive pulmonary disease.
Hooper C; Calvert J
Int J Chron Obstruct Pulmon Dis; 2008; 3(4):659-69. PubMed ID: 19281081
[TBL] [Abstract][Full Text] [Related]
13. Circadian variation of secretory IgA in nasal secretions from normal subjects.
Harada T; Hamaguchi Y; Sakakura Y; Miyoshi Y
Acta Otolaryngol; 1984; 97(3-4):359-62. PubMed ID: 6720311
[TBL] [Abstract][Full Text] [Related]
14. Immunoglobulin concentrations in serum and nasal secretions in chronic obstructive pulmonary disease. A matched-pair study.
Miller RD; Gleich GJ; Offord KP; Dunnette SL
Am Rev Respir Dis; 1979 Feb; 119(2):229-38. PubMed ID: 434595
[TBL] [Abstract][Full Text] [Related]
15. Deficiency of IL-5 receptor alpha-chain selectively influences the development of the common mucosal immune system independent IgA-producing B-1 cell in mucosa-associated tissues.
Hiroi T; Yanagita M; Iijima H; Iwatani K; Yoshida T; Takatsu K; Kiyono H
J Immunol; 1999 Jan; 162(2):821-8. PubMed ID: 9916704
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic behavior of S-carboxymethylcysteine-Lys in patients with chronic bronchitis.
Braga PC; Borsa M; De Angelis L; Bossi R; Allegra L; Scaglione F; Scarpazza G
Clin Ther; 1982; 4(6):480-8. PubMed ID: 7093981
[TBL] [Abstract][Full Text] [Related]
17. [Humoral mucosal immunity in allergic rhinitis].
Kramer MF; Jordan TR; Pfrogner E; Rasp G
Laryngorhinootologie; 2005 Jul; 84(7):503-10. PubMed ID: 16010632
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of the elastic and viscous components of bronchial mucus before and after S-carboxymethylcysteine-Lys treatment.
Braga PC; Bossi R; Allegra L
Int J Clin Pharmacol Res; 1984; 4(2):121-7. PubMed ID: 6469438
[TBL] [Abstract][Full Text] [Related]
19. Assessment of 7S and 11S immunoglobulin A in sputum.
Stockley RA; Afford SC; Burnett D
Am Rev Respir Dis; 1980 Dec; 122(6):959-64. PubMed ID: 7458067
[TBL] [Abstract][Full Text] [Related]
20. Tracheal and bronchial polymeric immunoglobulin secretory immune system (PISIS) development in a porcine model.
Guzman-Bautista ER; Ramirez-Estudillo MC; Rojas-Gomez OI; Vega-Lopez MA
Dev Comp Immunol; 2015 Dec; 53(2):271-82. PubMed ID: 26188097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
